Monday, December 29, 2025 10:12:27 AM
For the ASM today we were given these details
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177092240
If we use the 1st link, on the NWBO site there is the info that the meeting is at 2pm EST
If we go to the second link and log onto the Gibson Dunn Zoom portal, it shows up that the meeting starts at 5pm
Now if the 2pm EST is correct, then the time in UK will be 7pm (not 5pm)
and if the 5pm in UK is correct then the time in US (EST) would be 12 noon
So does anyone know for certain which one it is?
TIA
.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177092240
https://nwbio.com/annual-shareholder-meeting-2025/
The Annual Meeting may be accessed by stockholders and guests in audio-only mode by accessing https://gibsondunn.zoom.us/j/99677288547 and entering passcode: 424449.
If we use the 1st link, on the NWBO site there is the info that the meeting is at 2pm EST
STATEMENT REGARDING ACCESS TO AUDIO-ONLY CONNECTION FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 29, 2025
Northwest Biotherapeutics, Inc. (the “Company”) is hereby releasing an audio-only link to the Annual Meeting of Stockholders to be held on Monday, December 29, 2025 at 2:00 p.m. Eastern Time (the “Annual Meeting”).
If we go to the second link and log onto the Gibson Dunn Zoom portal, it shows up that the meeting starts at 5pm
Now if the 2pm EST is correct, then the time in UK will be 7pm (not 5pm)
and if the 5pm in UK is correct then the time in US (EST) would be 12 noon
So does anyone know for certain which one it is?
TIA
.
Potential CURE for cancer - DCVax could well be the biggest medical breakthrough - EVER
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
